I don't really understand why anybody would invest in CYP, they have clearly lost the race to Mesoblast hands down.
I believe that stem cell technology will be the future of medicine and Mesoblast will have a major piece of that action, that is why I have a significant holding in MSB.
If you really want to diversify in the Stem Cell arena take a look at Reneuron (RENE on AIM). Loaded exosome technology as a delivery system across the blood brain barrier. They are inking JVs with US Biopharma and have a market cap of just 42 million GBP.
I own shares in RENE but a much larger position in MSB.
MSB Trading - 2020, page-16698
-
- There are more pages in this discussion • 6,463 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |